Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

189 Press Releases
DateTitleCompany
07 Feb 14 Big Pharma pushes for U.S. action against India over patent worries Big Pharma,
Published by
Reuters
06 Feb 14 Bruce L.A. Carter Ph.D. Joins Biothera Board of Directors Biothera
06 Feb 14 AstraZeneca warns of tough year ahead. AstraZeneca,
Published by
Pharmiweb.com
03 Feb 14 Aesica appoints Ian Muir to newly created Commercial Managing Director position Aesica,
Published by
DeFacto Communication
29 Jan 14 Pcovery expands investor base with corporate investor Boehringer Ingelheim Venture Fund Boehringer Ingelheim
29 Jan 14 Philips launches new Healthcare Informatics Solutions and Services Business Group Philips Healthcare
29 Jan 14 'Bridge to Europe Package' Eases E.U. Pharmaceutical Sector Entry Consult Seuss
28 Jan 14 Data Presented Supporting Almac Developed Colon Signature as a Significant Predictor of Risk of Recurrence in Stage II Colon Cancer Almac,
Published by
DE Facto Communications
28 Jan 14 Aesica awarded NEPIC Industry Award Aesica Pharmaceuticals Ltd,
Published by
De Facto Communications
27 Jan 14 Philips launches new Healthcare Informatics Solutions and Services Business Group Royal Philips,
Published by
Philips Group Communications
27 Jan 14 NICE gives green light to first licensed treatment for patients suffering from potentially fatal forms of vasculitis National Institute for Health and Care Excellence,
Published by
reynoldsmackenzie
27 Jan 14 REAL WORLD ASTHMA STUDY SHOWS FOSTAIR® (EXTRA-FINE BECLOMETASONE-FORMOTEROL/efBDP-FOR) LESS COSTLY THAN FLUTICASONE-SALMETEROL (FP-SAL), WITH COMPARABLE OR IMPROVED OUTCOMES Chiesi Limited,
Published by
Munro & Forster
27 Jan 14 Otsuka and Lundbeck to present new data on brexpiprazole in major depression (MDD) at European Congress of Psychiatry (EPA) Otsuka Pharmaceutical Co Ltd,
Published by
Otsuka Pharmaceutical Co., Ltd.
27 Jan 14 Sanofi and MAbImprove LabEx (Tours) Join Forces on Treatment for Rare Lung Disease Sanofi
24 Jan 14 NICE gives green light to first licensed treatment for patients suffering from potentially fatal forms of vasculitis Roche
24 Jan 14 Prosonix Reports Positive Top-line Results from its Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Prosonix,
Published by
Citigate Dewe Rogerson
23 Jan 14 Biotec Services looks to build U.S. operation with new appointment Biotec Services International,
Published by
PharmiWeb.com
23 Jan 14 Government has made progress delivering Strategy for UK Life Sciences ABPI,
Published by
Association of the British Pharmaceutical Industry
23 Jan 14 Clasado and University of Oxford demonstrate effect of prebiotics on brain and gut in pre-clinical study Clasado and University of Oxford
23 Jan 14 New Doctors.net.uk service introduces doctors Doctors.net.uk,
Published by
Tala PR
23 Jan 14 Alexza Pharmaceuticals Announces Ferrer's Launch of ADASUVE® (Staccato® Loxapine) in Spain Triggering a $1 Million Milestone Payment Alexza Pharmaceuticals
23 Jan 14 International deal to screen potential cancer drugs using DNA ‘barcodes’ The Institute of Cancer Research
23 Jan 14 Exco InTouch Successfully Completes HIPAA Security Audit Exco InTouch,
Published by
De Facto Communications
21 Jan 14 New data reveals substantial variation in patients’ access to medicines across England Association of the British Pharmaceutical Industry,
Published by
Association of the British Pharmaceutical Industr
21 Jan 14 CPhI announces USA market report at InformEx CPhI Worldwide,
Published by
De Facto Communications
21 Jan 14 Global Sorbitol Demand to Reach 2.5 Million MT by 2017 IMARC Group
21 Jan 14 Almac publishes breast cancer chemotherapy response assay in the Journal of the National Cancer Institute Almac Group,
Published by
De Facto Communications
17 Jan 14 More Career Progression Opportunities With The Launch of SEC Management Academy SEC Management Academy
17 Jan 14 EFPIA Director General to present on The IMI program: Europe’s largest PPP SMi Group,
Published by
SMi Group Ltd
17 Jan 14 NEW FIRST-IN-CLASS EPILEPSY TREATMENT FYCOMPA® (PERAMPANEL) LAUNCHES IN SPAIN Eisai
Advertising